Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Peigen Huang, M.D.

Co-Author

This page shows the publications co-authored by Peigen Huang and Rakesh Jain.
Connection Strength

3.069
  1. Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas. Nat Commun. 2021 05 11; 12(1):2582.
    View in: PubMed
    Score: 0.246
  2. Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer model. Radiat Oncol. 2021 Mar 04; 16(1):48.
    View in: PubMed
    Score: 0.243
  3. In vivo compression and imaging in mouse brain to measure the effects of solid stress. Nat Protoc. 2020 08; 15(8):2321-2340.
    View in: PubMed
    Score: 0.233
  4. Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy. Proc Natl Acad Sci U S A. 2019 05 28; 116(22):10674-10680.
    View in: PubMed
    Score: 0.214
  5. Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer. Proc Natl Acad Sci U S A. 2019 03 05; 116(10):4558-4566.
    View in: PubMed
    Score: 0.210
  6. Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium. Nat Biomed Eng. 2019 03; 3(3):230-245.
    View in: PubMed
    Score: 0.210
  7. Quantifying solid stress and elastic energy from excised or in situ tumors. Nat Protoc. 2018 05; 13(5):1091-1105.
    View in: PubMed
    Score: 0.199
  8. MicroRNA-378 enhances radiation response in ectopic and orthotopic implantation models of glioblastoma. J Neurooncol. 2018 Jan; 136(1):63-71.
    View in: PubMed
    Score: 0.193
  9. Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy. Cancer Discov. 2016 08; 6(8):852-69.
    View in: PubMed
    Score: 0.175
  10. Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment. J Natl Cancer Inst. 2016 Feb; 108(2).
    View in: PubMed
    Score: 0.168
  11. Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels. Nat Commun. 2013; 4:2516.
    View in: PubMed
    Score: 0.138
  12. Spontaneous nonthymic tumors in SCID mice. Comp Med. 2011 Jun; 61(3):227-34.
    View in: PubMed
    Score: 0.124
  13. Histopathologic findings and establishment of novel tumor lines from spontaneous tumors in FVB/N mice. Comp Med. 2008 Jun; 58(3):253-63.
    View in: PubMed
    Score: 0.100
  14. Green fluorescent protein (GFP)-expressing tumor model derived from a spontaneous osteosarcoma in a vascular endothelial growth factor (VEGF)-GFP transgenic mouse. Comp Med. 2005 Jun; 55(3):236-43.
    View in: PubMed
    Score: 0.082
  15. Differential transplantability of tumor-associated stromal cells. Cancer Res. 2004 Sep 01; 64(17):5920-4.
    View in: PubMed
    Score: 0.077
  16. Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma. J Immunother Cancer. 2020 11; 8(2).
    View in: PubMed
    Score: 0.059
  17. Dual Programmed Death Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma. Hepatology. 2020 04; 71(4):1247-1261.
    View in: PubMed
    Score: 0.055
  18. A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma. Nat Protoc. 2019 02; 14(2):541-555.
    View in: PubMed
    Score: 0.053
  19. Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co-deliver MEK-inhibitors. Sci Rep. 2017 03 09; 7:44123.
    View in: PubMed
    Score: 0.046
  20. Anti-VEGF treatment improves neurological function and augments radiation response in NF2 schwannoma model. Proc Natl Acad Sci U S A. 2015 Nov 24; 112(47):14676-81.
    View in: PubMed
    Score: 0.042
  21. An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis. Nat Protoc. 2015 Aug; 10(8):1264-74.
    View in: PubMed
    Score: 0.041
  22. CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice. Hepatology. 2015 May; 61(5):1591-602.
    View in: PubMed
    Score: 0.040
  23. Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice. Hepatology. 2014 Apr; 59(4):1435-47.
    View in: PubMed
    Score: 0.037
  24. Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy. Proc Natl Acad Sci U S A. 2012 Oct 23; 109(43):17561-6.
    View in: PubMed
    Score: 0.034
  25. PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer. Clin Cancer Res. 2011 Jun 01; 17(11):3638-48.
    View in: PubMed
    Score: 0.031
  26. Responses to antiangiogenesis treatment of spontaneous autochthonous tumors and their isografts. Cancer Res. 2003 Feb 15; 63(4):747-51.
    View in: PubMed
    Score: 0.017
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.